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Abstract 
Ring shaped ocular inserts have been 
developed to administer a therapeutic level of 
tylosin tartrate throughout a five day period 
to treat pinkeye in cattle. The inserts are 
based on polyvinyl chloride rings which are dip 
coated with a copolymer containing the anti-
biotic (tylosin tartrate). Scanning electron 
microscope (SEM) characterization of surfaces 
has been of value to evaluate the presence and 
extent of surface flaws in the hydrogel coat-
ing, and to contribute to improvement in 
fabrication of the rings to insure the 
establishment of satisfactory seals at joints, 
uniformity of microporosity and cross sections, 
and the absence of significant cracking or 
flaking. In vitro release rates were deter-
mined using-thin layer chromatography tech-
niques, and rates were seen to be above a 
few micrograms of antibiotic p0r hour for 
experiments as long as nine days at simulated 
tear rates as high as 2 milliliters per hour. 
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Introduction 
The treatment of certain eye diseases can 
De significantly improved over that of conven-
tional treatments, such as eyedrops, by using 
controlled drug release ocular inserts. An 
example of a disease of potential interest where 
this type of treatment method could be 
advantageous is pinkeye in cattle. To be 
effective such inserts must release a thera-
peutic level of drug continuously, and must be 
non-irritating to the eye. Other factors, such 
as cost, are also important. Ideally, a bio-
erodable device might be preferred, but a 
device that will remain in place throughout an 
appropriate time period, and that can be easily 
removed, would certainly be satisfactory. 
The characteristics of pinkeye in cattle 
(Bovine Infectious Keratoconjunctivitis, BIK, 
or IBK) are lacrimation, photophobia, corneal 
ulcers, and corneal opacities. It is a 
contagious disease, and can result in signifi-
cant economic losses associated with weight 
loss and decrease in milk production. In the 
State of Iowa, six to ten percent of weaned 
beef calves suffer significant enough damage 
from pinkeye to reduce their economic value 
by 1/3 to 1/2. This represents a loss of tens 
of millions of dollars in Iowa alone. 
A virulent form of Moraxella bovis, a 
common agricultural bacterium, is t~primary 
infectious agent of BIK (Pugh and Hughes, 1968; 
Hughes and Pugh, 1970). Current medication 
application techniques exhibit severe drawbacks 
such as rapid removal of ointments or drops by 
tear fluids. The primary method for ocular 
delivery of antibiotic solutions is the use of 
eyedrops. A considerable fraction of an eye-
drop is lost immediately after instillation 
(about 80 percent in h~mans; Gelatt et al., 
1979); the primary disadvantage of usual 
aqueous eyedrop preparations is the short 
duration of drug action. For comparable time 
periods, sprays produce drug action results 
similar to those achieved by using eyedrops 
(Chiou and Watanabe, 1982). For example, a 
30 mg dose of tylosin tartrate 
[c 45H77No 17-c 4H6o 6 J applied to the eyes of 
cattle twice daily as a 50 milligrams/ml 
aqueous spray eliminated clinical signs of 
BIK and Moraxella bovis after five days (Ellis 
and Barnes, 1961); an in vitro test on a 
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Moraxella bovis isolate demonstrated inhibi-
tion by tylosin at a level of 0.4 micrograms 
per ml. This antibiotic also possesses 
inhibitory action on several members of the 
genus Mycoplasma, foe example. Recent work has 
shown that Mycoplasma bovoculi enhances the 
colonization of cattle eyes by Moraxella bovis 
(Rosenbusch, 1983, 1985; Rosenbusch and 
Knudtson, 1980). 
Improvements may be made in the admini-
stration of therapeutic levels of such an 
antibiotic by use of specialized ocular inserts 
for controlled release. Several studies have 
contributed supplemental information in support 
of this concept. For example, Hughes and Pugh 
(1975) found that 42.9 to 44.5 millimeter 
diameter rings constructed of polyvinyl 
chloride tubing (outside diameters of 2.82, 
1.65, or 0.914 millimeters) could be retained 
in the bovine eye. 0lanoff and co-workers 
(1979) demonstrated that certain hydrogel 
copolymers were capable of releasing microgram/ 
hour quantities of tetracycline (using 
copolymer areas and thicknesses roughly 
comparable to those of interest for potential 
ring-shaped ocular insert applications as will 
be described in the current work), a relatively 
large molecule, from a trilaminate delivery 
disk for periods of the order of months in in 
vitro diffusion studies using Ringer's solution 
[8.60 g NaCl, 0.30 g KCl, 0.33 g CaCl2 in 1.00 
1 aqueous solution) at 37° C. By varying the 
relative percentage of 2-hydroxyethyl 
methacrylate (hydrophilic monomer component) 
and methyl methacrylate (hydrophobic monomer 
component) of a copolymer, the diffusivity of 
the tetracycline through the copolymer could 
be varied over a range of values. Thus, this 
copolymer system appeared to offer general 
characteristics of interest for use in 
developing ring-shaped ocular controlled drug 
release devices in which an antibiotic such as 
tylosin tartrate could be of value. 
Hoffmann and Spadbrow (1978) reported 
mean lachrymal flow rates in cattle of 0.18-
1.86 ml/h; Slatter and Edwards (1982) 
measured mean flow rates of l.96+/-1.84 ml/h 
(+/-s.d.). Disease or other conditions will 
affect flow rates; a relatively high flow rate 
of 2 rnl/h was chosen as representative of a 
condition of irritation. The instantaneous 
volume of lachrymal fluid in the bovine eye may 
be approximated as 0.5 ml (R. Rosenbusch, 
personal communication). As the minimum 
inhibitory concentration for Moraxella bovis 
isolates is low, and of the order of 0.5 
microgram/ml (MIC; taken as the lowest concen-
tration of antimicrobial agent at which the 
tested organism did not show growth), desired 
drug release rates from the insert system would 
be anticipated to be at least of the order of 
a few micrograms/h. 
Materials and Methods 
Materials Fabrication 
Room temperature copolymerization accord-
ing to the method of 0lanoff and co-workers 
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(1979) is followed to make the copolymer used 
for dip coating. This is a batch process in 
which the copolymer forms throughout a ten day 
period. The following components are added 
together to obtain the desired 90 mole percent 
methyl methacrylate - 10 mole percent 
hydroxyethyl methacrylate bulk copolymer; 570 ml 
ethanol, 380 ml water (type-one), 6.1 ml 2-
hydroxyethyl methacrylate (Polysciences Inc., 
Warrington, PA; opthalmic grade), 46.6 ml methyl 
methacrylate, 0.25 g sodium persulfate, and 
0.13 g potassium persulfate. Throughout a ten 
day period, the solution is bubbled with nitro-
gen. At the end of the ten day period, the l 
liter solution and white copolymer precipitate 
is added to 3 liters of water, and the precipi-
tate copolymer is filtered and dried (50° C for 
five days, 635 mm Hg vacuum). 
Quantities of the copolymer are then dis-
solved in a suitable solvent and the drug is 
then mixed into the solution. This forms the 
dip coating material. For example, a repre-
sentative batch would consist of lg of co-
polymer and 20 ml of dimethyl formamide (stir-
red at 40-45° C for 6 hours). The solution is 
then cooled to room temperature before the 
addition of 0.5 g of tylosin tartrate. 
Vinyl tubing (polyvinyl chloride, medical 
grade, both regular (i.d. 0.112cm x o.d. 
0.165cm) and radiopaque (i.d. 0.086cm x o.d. 
0.117cm) varieties) is cut into suitable lengths 
(e.g., 126 mm long to permit making a ring 
40 mm in diameter). This tubing is threaded 
onto a wire which is subsequently bent into a 
ring shape prior to dipping. The dipping pro-
cedure is done in an inert atmosphere (nitrogen 
in a glove bag; Drierite desiccant) to insure 
uniformity of microstructure. To build up a 
sufficient amount of polymer and dissolved 
drug, ten to fifteen dips are made, and the sur-
face is allowed to dry between subsequent dips. 
The weight is monitored so that the amount of 
drug in a ring device is approximately 50 
milligrams. (Note that this total amount of 
drug loading per device is of the order of a 
typical single eyedrop application of anti-
biotic.) A thinner (i.d. 0.051cm x o.d. 0.091cm), 
1cm length of radiopaque polyvinyl chloride 
tubing is then wetted with either a polyvinyl 
chloride - tetrahydrofuran solution (5 weight 
percent PVC in tetrahydrofuran) or a solution 
of the copolymer in dimethyl formamide and 
inserted into the ends of the dipped ring 
shaped tubing (removing the wire mandrel first); 
this results in a strong joint, and completes 
the ring. 
Drug Release Characterization 
In vitro drug release experiments were con-
ductedusing Ringer's solution as an elution 
medium. The quantitative method for measuring 
drug release is based on thin layer chromato-
graphy (TLC) (Ryoo (1986)). The presence of 
salt broadens the spots used in the TLC method; 
however, the amounts of the drug are determinEd 
at the microgram level. 
For in vitro drug release experiments, a 
continuousflow apparatus was used and the salt 
solution flowed over the ring at a rate of 2 
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ml/hr. A 2 ml sample was collected on an 
hourly basis. A sample was dried, then 
redissolved in water to a suitable concentra-
tion level for spotting on 20 cm x 20 cm TLC 
plates. Several tests were done to insure that 
the concentration level was within a range for 
standards spotted on the same plate. Whatman 
LKC13F TLC plates were analyzed using a Kontes 
Fiber Optics Scanner (model 800) and a chart 
recorder. This type of TLC plate (linear-K 
plate with a preabsorbent area) uses a silica 
gel medium with hydrocarbonaceous functional 
groups covalently bonded to surface hydroxyls 
of the silica gel (related to the c18 part of 
the plate designation). Also, octadecylsilane 
is bonded to the silica gel. The material is 
fluorescent (absorbs 254 nanometer light), 
giving dark spots on a green background. To 
pcovide a more uniform visualization, the sili-
cone coating is first removed from a clean 
plate by treating the plate with methanol and 
drying. After this plate pretreatment, 2.5 
microliter droplets of the samples and stan-
dards are spotted onto the preadsorbent area 
of a plate (10 spots/plate), and dried at room 
temperature. The plate is developed in an 85% 
methanol - 15% water solution causing a spot 
migration of the order of 10 centimeters. The 
plates are then air dried for a 1 h period; 
ultraviolet light is then used to check the 
spots to insure that the drug release samples 
are within the concentration range represented 
by the standards on the same plate. Then the 
TLC plate is sprayed with a 10% H2so4 - 90% 
methanol solution (at a rate of 15 ml/min for 
15 sec). The plate is then placed in a pre-
heated oven at 100° C for 5 min. The spots 
will now be visible without the UV light. The 
plate is analyzed on the Kontes system within 
15 min of removal of a plate from the oven 
(fading occurs within 3 h). Each spot is 
analyzed twice; the peaks are cut from the 
chart paper, and are weighed. The quantity of 
drug in a release sample is determined by 
linear interpolation in reference to the peak 
weights for the standards (Touchstone and 
Dobbins (1978); Leytem (1984)). 
Scanning Electron Microscopy 
Before and after release experiments, 
representative hydrogel coated ring specimens 
are cut into 1 cm lengths. In vitro release 
experiment samples are usually air dried, and 
mounted on carbon stubs. Some samples are 
critical point dried in a Polaron Model E3000 0 
drier using CO2. The specimens receive a 300 A 
coating of gold (Polaron E5100 sputter coater), 
and then are examined using an SEM (JEOL U3 
equipped with an energy dispersive X-ray analy-
sis system and JSM 840-A; the photos which are 
shown were obtained from the JSM 840-A). 
Operating conditions
0
of relatively low probe 
current (~3 x 10-ll A) and relatively low 
accelerating voltages (5-10 kV) are generally 
preferred to avoid beam damage to sample sur-
faces. An energy dispersive X-ray analysis 
(Tracor Northern - 2000 energy dispersive 
analysis system; Kevex detector) is also done 
on the PVC source material to monitor the 
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The surface of the uncoated polyvinyl 
chloride (PVC) tubing is smooth (Figure la-
lb). By comparison, the surface of the un-
coated radiopaque PVC tubing is rough (Figure 
2). The hydrogel coating that results from the 
dip processing is also smooth. Only minor sur-
face blemishes are seen on such surfaces. 
Typically the hydrogel-antibiotic mixture is 
built up as a result of several consecutive 
coatings, and as a result the hydrogel surfaces 
on the radiopaque PVC tubing appear smooth. 
The exposure to the elution solution for the 
nine day test periods does not appear to alter 
the surface appearance (Figure 3). Since the 
elution solution was Ringer's, a number of small 
sodium chloride crystals are seen on the hydro-
gel surface after a test. Ring device joints 
should be monitored to avoid forming rough por-
tions of a ring such as that seen in Figure 4. 
Also, attempts to smooth dip coated surfaces 
with a brush before the coating hardens can 
result in forming a variety of surface 
grooves. Although such surface features are 
small, and probably would cause no major 
problems in using a ring with such features 
as an insert in the eye of a cow, such 
handling is unnecessary, and should be 
avoided. 
Microchemistry 
The use of energy dispersive X-ray 
analysis shows the presence of a chemical 
difference between the two types of PVC 
tubing. An analysis performed on a gold 
coated segment of plain PVC tubing shows the 
presence of the gold (300 angstrom coating 
thickness) and the chlorine of the underlying 
PVC tubing (Figure 5). By comparison, in 
addition to these peaks, the presence of 
iodine is seen in the radiopaque PVC tubing 
(Figure 6). Also note that the hydrogel 
coating completely covers these surfaces to 
a thickness of approximately 0.025cm (dry 
state; spectrum shown in Figure 7). These 
chemical elements, as well as other com-
ponents such as plasticizers, which are in the 
medical grade PVC tubings, are not expected to 
cause eye irritation during the typical 
insertion periods of several days (based on 
observations reported in the literature by 
Hughes and Pugh). 
Release Rates 
Within the first 8 h of contact with the 
elution solution, the maximum release rate is 
seen (Figure 8a-8c). For typical ring 
devices, such as those listed in Table 1, 
(hydrogel coated radiopaque PVC for these 
cases) the maximum rate is of the order of 
several hundred micrograms per hour. After the 
release rate peak is reached, the release rate 
falls off rapidly. During the first three days 
of a release experiment, the release rate of 
antibiotic is above 50 micrograms per hour. At 
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Figure la. Plain PVC tubing surface (before 
dip coating). 
Figure lb. Higher magnification view of plain 
PVC sample of Figure la. 
Figure 2. Radiopaque PVC tubing surface (before 
dip coating). Compare with Figure lb, and note 
that the surface of this type of PVC tubing is 
relatively rough (extrusion marks). 
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Figure 3. Hydrogel surface coating on radiopa-
que PVC tubing after 9-day in vitro antibiotic 
release test. Arrow indicaee"s sodium 
chloride residue from the Ringer's solution. 
Note that the hydrogel surface is smooth and 
similar to that for a sample prior to a drug 
release test (i.e., similar smoothness and 
no salt crystals). 
-0020 5KU X40 100~m WD25 
Figure 4. lncomplete seal of a PVC ring joint; 
hydrogel coated radiopaque tubing. 
nine days, the release rate is seen to be at 
least 3 micrograms per hour. 
Conclusion 
The physical and chemical characteristics 
of the ring device appear to be satisfactory 
for use as an ocular insert for cattle. The 
in vitro tests were performed on rings of 
sizes of interest for use as ocular inserts 
for cattle (results were reported above for a 
typical diameter and circumference that might 
be needed; for best retention, Hughes and 
Pugh (1975) recommend that such devices meet 
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Figure 5. Energy dispersive X-ray analysis 
spectrum obtained from gold coated PVC tubing. 
Au peaks are due to the gold coating, and the 
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Figure 6. Energy dispersive X-ray analysis 
spectrum obtained from gold coated radiopaque 
PVC tubing. Au peaks are due to the gold 
coating, and the Cl and I peaks are due to the 
chlorine and iodine in the PVC. 











Figure 7. Hydrogel coated radiopaque PVC 
tubing. The presence of the coating 
suppresses the Cl signal from the PVC. 
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the following criterion: rings should have a 
circumference smaller than that of the con-
junctiva! sac, but larger than that of the 
globe of the eye). The hydrogel coating 
appears to release a sufficient amount of 
antibiotic to remain above the minimal 
inhibitory concentration necessary to 
suppress bacterial growth. It is antici-
pated that the inserts would be effective 
for therapeutic administration of the 
antibiotic throughout a 5 to 7 day period at a 
rate at least of the order of a few micrograms 
per hour. For the tearing rate ranges 
reported for cattle, the ocular insert proto-
type has potential application in treating 
pinkeye in cattle. 
Acknowledgements 
This work was supported by a grant from 
the U.S. Department of Agriculture and by 
funds contributed in part by the Engineering 
Research Institute. 
References 
1. Chiou GCY, and Watanabe K. (1982) Drug 








Ellis LF, and Barnes LE. (1961) Tylosin 
treatment of bovine pink eye. Vet. Med., 
56, 197. 
Gelatt KN, Gum GG, Williams LW, and 
Peiffer RL. (1979) Evaluation of a 
soluble sustained-release 
delivery unit in the dog. 
Res., 40 702-704. 
opthalmic 
Am. J. Vet. 
Hoffmann D, and Spadbrow SP. (1978) A 
method of collecting lachrymal fluid from 
cattle. Res. Vet. Sci., l.2_, 103-104. 
Hughes DE, and Pugh GW. (1970) A five-
year study of IBK in a beef herd. J. Am. 
Vet. Med. Assoc., 157, 433-451. 
Hughes DE, and PughJr. GW, (1975) 
Infectious bovine keratoconjunctivitis: 
a ring device designed for prolonged 
retention in the bovine eye. Am. J. 
Vet. Res., ]_6, 1043-1045. 
Leytem BA. (1984) Tylosin tartrate 
release from hydrogel ocular inserts. 
MS thesis, Iowa State University, Ames, 
70-74 . 
8. Olanoff L, Koinis T, and Anderson JM. 
(1979) Controlled release of tetra-
cylcine I: in vitro studies with a 
trilaminate 2-hydroxyethyl methacry-
late - methyl methacrylate system. J. 
Pharmaceutical Sciences, 68, 1147-1150. 
9. Pugh GW, and Hughes DE. (1968) 
Experimental BIK caused by sunlamp 
irradiation and Moraxella bovis infection: 
correlation of hemolytic ability and 
pathogenicity. Am. J. Vet. Res.,~. 
835-839. 
10. Rosenbusch RF. (1983) Influence of 
mycoplasma preinfection on the expression 
of Moraxella bovis pathogenicity. Am. J. 
Vet. Res., 44~1-1624. 
R. T. Greer and J. P. Ryoo 
























tl II! 5 ... -'---_.__ L __ .L_L _J__ _!_ 
a 24 "' 12 96 1211 144 168 192 216 ( 8 a ) 





.s::. 6llll '• 


















j._<><1t-· .. o\o.•. .Joa1l•ool. ■ J.......J 
48 72 96 1211 144 188 192 216 
R£!.ERSE Til1E 111!1 
48 12 96 12ll 144 1sa 192 216 l 8 bl 









~ 4811 ~-= ft-'!. 
~ 21!1111 
UIJ ~-a. 
a .. ~ -~--·L1,,._0_--~1~ .. t! . ..l!-R ol,, .•. .Jo ..... J o-1.. 
a 24 48 12 96 1211 144 168 192 216 
ftELfRSf Til1E ltfll 
Release Rate Total Total Released 
Total Loading 
(%) 
























l 8 c I a 24 48 12 96 122 144 168 191 :216 
RELERSE T !HE !MRI -Bell 
700 
I- g 
.c 6l!ll ..___ 
0) 
::J. 
Sllll ~ -w • f- 3l!ll : 
<C ~E b Cl'.'. o ... -~--1~ 0 _•_·•~\~ 0 . ~loo■•J......-l.,. .. 
a 24 48 72 96 121! 144 168 192 216 
RELERSE TIME !MRI 
Figure 8. Curves of the release rate of the 
antibiotic (µg/hr) versus time (hr) and of the 
total amount of antibiotic released (mg) as a 
function of time (hr) obtained from hydrogel 
coated PVC rings (50 mg antibiotic loading; 
40 mm diameter). (a) Ring device 061, (b) ring 
device 062, and (c) ring device 063. 
11. Rosenbusch RF. ( 1985) Bovine pinkeye -
etiology and pathogenesis. The Bovine 
Practitioner, No. 20, 150-152. 
12. Rosenbusch RF, and Knudtson WU. (1980) 
Bovine mycoplasmal conjunctivitis: 
experimental reproduction and 
characterization of the disease. 




Ryoo JP. (1986) In vitro studies of the 
release of tylosin tartrate from hydrogel 
ocular inserts. MS thesis, Iowa State 
University, Ames, 44-47. 
Slatter DH, and Edwards ME. (1982) 
Normal bovine tear flow rates. Res. Vet. 
Sci., _::31, 262-263. 
Touchstone JC, and Dobbins MF. (1978) 
Practice of thin layer chromatography. 
Wiley-Interscience, NY, 383 pp. 
Ocular Inserts for Cattle 
Discussion with Reviewers 
Cristopher D. Batich and Moshe Yalon: Has any 
monomer or oligomer extraction been studied for 
potential toxic effects on the eye? 
Authors: We have not done such studies. 
Alan H. Brightman: Was there another co-
polymer precipitated and studied? 
Authors: A relatively hydrophilic formulation 
of 75 mole percent hydroxyethyl methacrylate -
25 mole percent methyl methacrylate (25 MMA: 
75 HEMA) was also studied. The release rate 
profiles for ring devices utilizing a coating 
of this formulation were similar to that of 
the 90:10 copolymer coatings reported above. 
The 25 MMA:75 HEMA formulation was studied as 
a type of matrix for the antibiotic that 
would be expected to exhibit minimal eye 
irritation. No overt inflammation was 
observed in limited preliminary in vivo 
testing of the 90:10 copolymer coating on a 
ring device (1 week). No in vivo tests have 
been done using the 25 MMA~S HEMA formulation. 
Cristopher D. Batich and Moshe Yalon: Why are 
different release rates seen for the three 
samples? Are the same thickness coatings used? 
Authors: The PVC tubing shrinks (shortens) in 
response to the solvent of the dipping treat-
ment. The coating thicknesses are about the 
same in each case; however, the tube lengths 
vary. The longer a tube, the more surface 
area, and the greater the amount of drug 
release during the sampling periods. 
Alan H. Brightman: Do the authors feel that 
other antibiotics could be incorporated into 
this coating? 
Authors: Yes. Other antibiotics such as 
lincomycin are of interest. However, you need 
a sensitive method to quantify the release of 
particular antibiotics for the time period of 
interest. 
Cristopher D. Batich and Moshe Yalon: What is 
the source of the PVC tubing? Many varieties 
are commercially available. 
Authors: The source of the PVC for the 
experiments reported above is Becton, 
Dickinson and Co., Rutherford, NJ. The PVC 
material with iodine is the transparent/ 
radiopaque type (Clearex #15654 and #15652, 
sizes 0.086cm i.d. x 0.117cm o.d. and 0.051cm 
i.d. x 0.091cm o.d., respectively). The other 
variety is plain medical grade vinyl tubing 
(B-D #6179; 0.112cm i.d. x 0.165 cm o.d.; 
discontinued). 
Alan H. Brightman: If the devices are used as 
intended, does the coating withstand physical 
handling necessary to insert a ring into a 
cow's eye? 
Authors: Yes. A ring is placed in physiologi-
cal saline for 8-12 h prior to insertion. This 
is a preconditioning step to soften the 
hydrogel coating. 
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Cristopher D. Batich and Moshe Yalon: After 
testing release rates, had the hydrogel been 
damaged? Mechanical properties of hydrogels 
are very poor and one would expect significant 
abrasion in vivo. 
Authors: No--:---i>lease refer to Figure 3 in the 
paper for an in vitro example, and to Figure 9 
(below) for a-;:;:--in vivo example. Preliminary in 
vivo experiments are being conducted in 
collaboration with Dr. R. Rosenbusch (Veterinary 
Medical Research Institute, Iowa State 
University). Problems of insertion and reten-
tion of rings have been identified, and 
associated studies are in progress. 
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Figure 9. Surface of an ocular insect after a 
7-day in vivo antibiotic release experiment in 
th1e eye ofa healthy cow. Notice that the 
hY'drogel surface is intact. (Sample was fixed 
in a 3% glutaraldehyde solution, critical 
paint dried using co2 , and gold coated prior to 
SEM examination). 
R. Holm: In figure 7, why is iodine detected 
while chlorine is not? Did iodine migrate into 
the hydrogel? 
Authors: Chlorine X-rays are absorbed by the 
thickness of the hydrogel coating, whereas 
those from iodine are less affected and can be 
detected by energy dispersive X-ray analysis in 
this case. 
R. Holm: Does the tylosin tartrate exhibit 
cathodoluminescence? 
Authors: We do not have cathodoluminescence 
information. However, optical fluorescence of 
the powder is excited by short wavelength 
(254 nm) ultraviolet light (brown fluorescence 
emission), by long wavelength (365 nm) ultra-
v~olet light (bright yellow fluorescence 
emission), or by both short and long wavelength 
ulitraviolet light (dark brown fluorescence 
emission). This is of interest in a general 
way in the TLC method. In spotting the anti-
b~otic on the TLC plates, ultraviolet light can 
be used to excite a green luminescence for the 
pliate, whereas the antibiotic spots appear 
bliack (for both long and short wavelength 
ulitraviolet and combined ultraviolet). 

